tiprankstipranks
Gelteq Limited (GELS)
NASDAQ:GELS
US Market
Holding GELS?
Track your performance easily

Gelteq Limited (GELS) Stock Price & Analysis

3 Followers

GELS Stock Chart & Stats


GELS FAQ

What was Gelteq Limited’s price range in the past 12 months?
Gelteq Limited lowest stock price was $1.42 and its highest was $4.01 in the past 12 months.
    What is Gelteq Limited’s market cap?
    Currently, no data Available
    When is Gelteq Limited’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Gelteq Limited’s earnings last quarter?
    Currently, no data Available
    Is Gelteq Limited overvalued?
    According to Wall Street analysts Gelteq Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Gelteq Limited pay dividends?
      Gelteq Limited does not currently pay dividends.
      What is Gelteq Limited’s EPS estimate?
      Gelteq Limited’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Gelteq Limited have?
      Gelteq Limited has 9,438,075 shares outstanding.
        What happened to Gelteq Limited’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Gelteq Limited?
        Currently, no hedge funds are holding shares in GELS
        ---

        Gelteq Limited Stock Smart Score

        Company Description

        Gelteq Limited

        A "white label" gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals-for pets, sports, pharmaceutical (pharma), over-the-counter (OTC) and nutraceutical-all of which leverage our patent pending multiple-ingredient dosage forms, and that we expect to have a wide range of applications and consumers. We currently focus our efforts on out-licensing our technology to companies to develop and create new products they can manufacture and sell within their established and researched markets, while we continue to manufacture our existing products under license. Of our products already licensed, two clients have placed initial orders for nutraceutical products, and there have been four other products in the sports vertical ordered.
        ---
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis